A Study Of Confocal Laser Endomicroscopy (CLE) With The InVue® And InForm™ During Head And Neck Cancer (HNC) Surgery

Overview

About this study

The purpose of this study is to assess the safety and effectiveness of contrast-enhanced CLE imaging of head and neck tissue with the InVue® and InForm™ systems.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion criteria:

  • Patients ≥18 years of age with known HNC limited to the oral cavity, oropharynx or base of the tongue and requiring surgical intervention as standard therapy

Exclusion Criteria:

  • Patients ˂ 18 years of age, who experience poor functional status or with cancers planned for palliative management only, who have ahistory of allergy to fluorescein or hypersensitivity responses, or who are unable to complete study consent

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 02/09/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kyle Ettinger, M.D., D.D.S.

Contact us for the latest status

Contact information:

Jennie Musty

5075384849

musty.jennie@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20608098

Mayo Clinic Footer